国际鞍结节脑膜瘤研究:手术结局与管理趋势
这项40中心回顾性研究纳入947例鞍结节脑膜瘤,经颅入路占66.4%、扩大内镜经鼻入路占33.6%。两组全切除率无差异,内镜组视觉改善率更高但脑脊液漏率也更高;作者认为对适当选择的病例内镜入路可能更优,但需更长随访。
要点
- 内镜经鼻入路组术前有视觉缺损者视觉改善率73.0%,高于经颅入路组的57.1%(P<.0001)。
- 内镜经鼻入路脑脊液漏率17.3%,经颅入路2.2%(OR 9.1,P<.0001)。
- 全切除后内镜组复发率低于经颅组(OR 0.33,P=.0027)。
核心结论
- 对适当选择的鞍结节脑膜瘤,扩大内镜经鼻入路可能带来更好的视觉结局和全切除后更低的复发率,但脑脊液漏率较高,且需要更长的随访。
- 内镜组肿瘤更小、随访更短,反映选择偏倚和观察偏倚;尽管如此,作者认为对适当选择的鞍结节脑膜瘤,内镜经鼻入路可能优于经颅入路。
研究设计与样本
- 这是一项40家中心参与的回顾性研究,采用标准统计方法,共纳入947例鞍结节脑膜瘤病例。
主要发现
- 经颅入路使用66.4%,扩大内镜经鼻入路使用33.6%;经颅入路组最大径中位数2.5 cm,内镜组2.1 cm(P<.0001);随访中位数26个月。
- 全切除率70.2%,内镜组与经颅组之间无差异(P=.5395);视力相同或更好者占87.5%。
- 术前有视觉缺损者中,内镜组视觉改善73.0%,经颅组57.1%(P<.0001)。
- 多因素分析中,经颅入路与视力恶化相关(OR 1.78,P=.0258),全切除为保护因素(OR 0.37,P<.0001);全切除率随最大径增大而下降(每cm OR 0.80,P=.0036),术前有视觉缺损者全切除率亦下降(OR 0.56,P=.0075)。
- 死亡率0.5%,并发症发生率23.9%;新发单侧失明3.3%、双侧失明0.4%;脑脊液漏率内镜组17.3%、经颅组2.2%(OR 9.1,P<.0001)。
临床怎么用
- 作者认为,对适当选择的鞍结节脑膜瘤,扩大内镜经鼻入路可能优于经颅入路。
局限性
- 内镜组肿瘤更小且随访更短,反映选择偏倚和观察偏倚。
- 脑脊液漏率较高。
- 需要更长的随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Tuberculum sellae meningiomas (TSMs) can be resected through transcranial (TCA) or expanded endonasal approach (EEA). The objective of this study was to report TSM management trends and outcomes in a large multicenter cohort. METHODS: This is a 40-site retrospective study using standard statistical methods. RESULTS: In 947 cases, TCA was used 66.4% and EEA 33.6%. The median maximum diameter was 2.5 cm for TCA and 2.1 cm for EEA ( P < .0001). The median follow-up was 26 months. Gross total resection (GTR) was achieved in 70.2% and did not differ between EEA and TCA ( P = .5395). Vision was the same or better in 87.5%. Vision improved in 73.0% of EEA patients with preoperative visual deficits compared with 57.1% of TCA patients ( P < .0001). On multivariate analysis, a TCA (odds ratio [OR] 1.78, P = .0258) was associated with vision worsening, while GTR was protective (OR 0.37, P < .0001). GTR decreased with increased diameter (OR: 0.80 per cm, P = .0036) and preoperative visual deficits (OR 0.56, P = .0075). Mortality was 0.5%. Complications occurred in 23.9%. New unilateral or bilateral blindness occurred in 3.3% and 0.4%, respectively. The cerebrospinal fluid leak rate was 17.3% for EEA and 2.2% for TCA (OR 9.1, P < .0001). The recurrence rate was 10.9% (n = 103). Longer follow-up (OR 1.01 per month, P < .0001), World Health Organization II/III (OR 2.20, P = .0262), and GTR (OR: 0.33, P < .0001) were associated with recurrence. The recurrence rate after GTR was lower after EEA compared with TCA (OR 0.33, P = .0027). CONCLUSION: EEA for appropriately selected TSM may lead to better visual outcomes and decreased recurrence rates after GTR, but cerebrospinal fluid leak rates are high, and longer follow-up is needed. Tumors were smaller in the EEA group, and follow-up was shorter, reflecting selection, and observation bias. Nevertheless, EEA may be superior to TCA for appropriately selected TSM.
引用
- Magill ST, Schwartz TH, Couldwell WT, et al. International Tuberculum Sellae Meningioma Study: Surgical Outcomes and Management Trends. Neurosurgery. 2023. PMID: 37389475. doi:10.1227/neu.0000000000002569
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。